The enzyme Glucosamine-6-phosphate deaminase catalyzes the reversible reaction between glucosamine-6-phosphate (Glu6P) and fructose-6-phosphate (Fru6P) and ammonium.
With the aim to study the structure of the Michaelis complex, we crystallized the protein in sodium acetate 2.8M, HEPES 100mM pH 7.5 and Fru6P 27mM at 18ºC.
In this way, the absence of ammonium allows the access of Fru6P into the active site (Ac.S.), but not the conversion to Glu6P.
The structure was solved using Molecular Replacement in XPLOR.
Acknowledgements: We wish to thank Dr. Mario Calcagno for supplying the purified protein, Sonia Rojas-Trejo for technical assistance in crystal growth and to the Stanford Synchrotron Radiation Laboratory (SSRL) for data collection time.
mono_glucosamine_sulfate_vq155
Provides clinical efficacy in the treatment of osteoarthritis equal to the symptomatic relief offered by NSAIDs but without significant side effects.
Clinical efficacy documented far more substantially than glucosamine hydrochloride, N-acetyl glucosamine, and chondroitin sulfate.
Natural amino sugar, readily soluble in water and easily absorbed into the blood stream through the intestinal mucosa (90-98%) via active transport, Small molecular size allows it to cross blood-synovial barrier, diffuse through the cartilage, and enter the chondrocytes.
Contains the sulphur moiety that is essential to the formation of appropriate crosslinking of connective tissue fibers, providing a strong and resilient tissue structure.
3. Bassleer C, et al, Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.
jillors http://www.obl.msu.edu/RESABS/jillors.PDF
loading, explants, cell, high-rate, media, cartilage, cell death, controls, GS-treated group, tissue, low-rate, matrix damage, amount, weight, compression.
Numerous studies have shown that mechanical loads can generate matrix damage and cell death in cartilage explants5,6.
This study indicated that relatively more matrix damage for high-rate loading is contrasted with more cell death in low-rate experiments.
36 explants were placed in DMEM:F12 media, while the remaining 36 were placed in media with 2.5 mg/ml GS.
However, there was a significant decrease in compression from 0.32 ± 0.04mm in the without GS group to 0.29 ± 0.04mm in the GS-treated group.
The amount of PG released to the media after one day for non-impacted controls was higher for the GS-treated group than for the without-GS group (Fig. 2).
BRAH1
knee pain, glucosamine, glucosamine supplementation, placebo group, regular knee pain, report, KOOS, experience regular knee, pain relief, self report, lower KPS scores, life scores, KOOS quality, Self-rated improvements, nonsignificant.
The present study examined the effects of glucosamine supplementation on functional ability and pain felt by individuals who had regular knee pain.
Self-rated improvements in knee pain immediately after the tests were, however, larger in the glucosamine group, who had significantly better KOOS quality of life scores at week 8 and 12 (p<0.05), and lower KPS scores (p<0.05) at week 8 than the placebo group.
On self report, 88% of the glucosamine group reported improvements in their knee pain versus only 17% in the placebo group.
The results suggest that glucosamine supplementation can provide pain relief and improved function in persons who experience regular knee pain.
proHealthGlucosamine
arthritis, chondroitin, glucosamine, pain, evidence, Recommendation, costs, acute injuries, substances, shark cartilage, Review, WorkCover, medical advisor, agents, approx.
Glucosamine and chondroitin are over the counter tablets and capsules, often derived from shark cartilage, marketed for the temporary relief of arthritis.
Scientific evidence has recently been published which supports benefit from the use of glucosamine and/or chondroitin for people with pain and disability due to arthritis.
There is no evidence to support the use of these substances for acute injuries.
Reimbursement of costs is appropriate if their use has been recommended by an approved medical expert, for arthritic pain caused by or aggravated by a compensable injury.
Claim's agents should contact their medical advisor if they have concerns about an amount charged.
BRAH1
knee pain, glucosamine, glucosamine supplementation, placebo group, regular knee pain, report, KOOS, experience regular knee, pain relief, self report, lower KPS scores, life scores, KOOS quality, Self-rated improvements, nonsignificant.
The present study examined the effects of glucosamine supplementation on functional ability and pain felt by individuals who had regular knee pain.
Self-rated improvements in knee pain immediately after the tests were, however, larger in the glucosamine group, who had significantly better KOOS quality of life scores at week 8 and 12 (p<0.05), and lower KPS scores (p<0.05) at week 8 than the placebo group.
On self report, 88% of the glucosamine group reported improvements in their knee pain versus only 17% in the placebo group.
The results suggest that glucosamine supplementation can provide pain relief and improved function in persons who experience regular knee pain.
proHealthGlucosamine
arthritis, chondroitin, glucosamine, pain, evidence, Recommendation, costs, acute injuries, substances, shark cartilage, Review, WorkCover, medical advisor, agents, approx.
Glucosamine and chondroitin are over the counter tablets and capsules, often derived from shark cartilage, marketed for the temporary relief of arthritis.
Scientific evidence has recently been published which supports benefit from the use of glucosamine and/or chondroitin for people with pain and disability due to arthritis.
There is no evidence to support the use of these substances for acute injuries.
Reimbursement of costs is appropriate if their use has been recommended by an approved medical expert, for arthritic pain caused by or aggravated by a compensable injury.
Claim's agents should contact their medical advisor if they have concerns about an amount charged.
glucosamine
glucosamine, pain, treatment, patients, osteoarthritis, review, drugs, efficacy, therapy, London, compare, Vaz, Qui, randomisation, analgesics.
The clinical features include joint pain, stiffness, swelling and loss of function.
For some years glucosamine, widely available as a supplement from health-food shops and pharmacies, has been advocated as an alternative or additional treatment.
Due to the apparent faster onset of action both glucosamine and ibuprofen could be taken initially to manage pain relief, and once the effects of glucosamine are established, ibuprofen therapy could be reduced or withdrawn, depending on the circumstances.
The trials included in the review are relevant to community practice; doses of both drugs are similar to those used and available, and even though some of the participants were hospital outpatients, the results are likely to be applicable to a range of patients with mild to moderate osteoarthritis.
77-86s
ADGP, cells, inhibitory, determinations, GlcN-6-P synthase, FMDP, agents, albicans, buffer, uptake, liposomes, glucose, AMB, mg/ml, MF-AME.
In the present studies we have exploited the possibility of enhancement of ADGP and FMDP antifungal activity by improving their transport properties.
It has been found that membrane-permeabilising polyene macrolides amphotericin B (AMB) and its N-methyl-N-fructosyl methyl ester derivative (MF-AME), at subinhibitory concentra tions, facilitate diffusion of ADGP through the fungal cell membrane, thus allowing a decrease of its minimal inhibitory concentration (MIC).
Another possibility of efficient delivery into cells of non-diffusible compounds is their encapsulation into lipidic vesicles.
Kinetic analysis of ADGP uptake by albicans cells.
One of them was a combined ac tion of the inhibitors with membrane-active antifungal agents, AMB or MF-AME.
23
osteoarthritis, glucosamine, patients, treatment, drug, report, safety, progression, cartilage, placebo, knee, chondrocytes, Glucosamine Sulfate, symptoms, aggrecan.
Health Economics at the University of Liège, where he is also the Head of the Bone and Cartilage Metabolism Unit.
Efficacy and safety of GS were tested in several randomised, controlled clinical trials that included patients with osteoarthritis, predominantly of the knee or spine.
All of the reported complaints were reversible with discontinuation of GS.24 While some questions were raised regarding the role of glucosamine in glucose metabolism25 and the possibility of increased insulin resistance, a detailed review of scientific studies performed with GS ruled out this possibility and re-emphasised the safety of short and long-term use of GS.26 While in Europe GS is regarded as a medication and is thus subject to the usual quality controls, this is not the case in either Canada or the US.
elizabeth01-preferential
cartilage, GlcN, spectrum, carbon-13, resonance, ppm, proteoglycan, Glc, glucosamine, metabolism, chondroitin, peak, culture, control, GalNAc.
To determine the metabolic fate of glucosamine (GlcN) in intact articular cartilage tissue.
The metabolic products of the labeled precursors were determined from the MRS data based on resonance positions and comparison with known standards and published values.
The C-3 carbon of lactate at 19.5 ppm is not apparent in the control spectrum but can be observed in the labeled Glc spectrum in Figure 2C.
A spectrum from control, unlabeled cartilage is shown for comparison.
At this time, it is not known what molecular species corresponds to this resonance.
However, this peak was conspicuously absent in the sample maintained with GlcN.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 14 | 15 | 16 | 17 |
